References
- Popovich R P, Moncrief J W, Nolph K D, et al. Continuous ambulatory peritoneal dialysis. Ann Intern Med 1978; 88: 449–456
- Fremstad D, Nilsen O G, Storstein L, et al. Pharmacokinetics of quinidine related to plasma protein binding in man. Europ J Clin Pharmacol 1979; 51: 187–192
- Ueda C T, Hirschfed D S, Scheinman M M, et al. Disposition kinetics of quinidine. Clin Pharmacol Ther 1976; 19: 30–36
- Drayer D E, Lowenthal D T, Restivo K M, et al. Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function. Clin Pharmacol Ther 1978; 24: 31–39
- Greenblatt D J, Pfeifer H J, Ochs H R, et al. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration. J Pharmacol Exp Ther 1977; 202: 365–378
- Conrad K A, Molk B L, Chidsey CA. Pharmacokinetic studies of quinidine in patients with arrhythmias. Circulation 1977; 55: 1–7
- Kessler K M, Lowenthal D T, Warner H, et al. Quinidine elimination in patients with congestive heart failure or poor renal function. N Engl J Med 1974; 290: 706–709
- Reimold E W, Reynolds W J, Fixler D E, et al. Use of hemodialysis in the treatment of quinidine poisoning. Pediatrics 1973; 52: 95–99
- Wole L, Oyri A. Quinidine intoxication treated with hemodialysis. Acta Med Scand 1974; 195: 237–239
- Perez-Mateo M, Erill S. Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency. Europ J Clin Pharmacol 1977; 11: 225–231
- Reidenberg M M, Affrine M. Influence of disease on binding of drugs to plasma proteins. Ann NY Acad Sci 1973; 226: 115–126